Pancreatic cancer screening: Difference between revisions
Jump to navigation
Jump to search
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
In asymptomatic adults who are at average risk, the U.S.P.S.T.F recommends against routine screening for pancreatic cancer due to the lack of mortality benefit. In high-risk individuals, with familial pancreatic cancer or in those with genetic syndromes predisposing to pancreatic cancer, screening is suggested. Screening with diagnostic modalities such as the CT or EUS may be helpful | |||
==Screening== | ==Screening== |
Revision as of 18:26, 15 November 2017
Pancreatic cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pancreatic cancer screening On the Web |
American Roentgen Ray Society Images of Pancreatic cancer screening |
Risk calculators and risk factors for Pancreatic cancer screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
In asymptomatic adults who are at average risk, the U.S.P.S.T.F recommends against routine screening for pancreatic cancer due to the lack of mortality benefit. In high-risk individuals, with familial pancreatic cancer or in those with genetic syndromes predisposing to pancreatic cancer, screening is suggested. Screening with diagnostic modalities such as the CT or EUS may be helpful
Screening
- In asymptomatic adults who are at average risk, the U.S.P.S.T.F recommends against routine screening for pancreatic cancer due to the lack of mortality benefit.
- In high-risk individuals, with familial pancreatic cancer or in those with genetic syndromes predisposing to pancreatic cancer, screening is suggested. Screening with diagnostic modalities such as the CT or EUS may be helpful.[1] [2]
- Individuals with the following conditions are also at an increased risk of pancreatic cancer:[3]
- Hereditary pancreatitis
- Familial pancreatic cancer
- Peutz-Jeghers disease
- Familial atypical mole melanoma syndrome (FAMMM)
- Cystic fibrosis of pancreas,
- Familial cancer syndromes such as:
- Lynch syndrome
- Familial adenomatous polyposis (FAP)
- von Hippel-Lindau syndrome
- Multiple endocrine neoplasia type 1
- Hereditary breast and ovarian cancer-BRCA1 and BRCA2 mutations
References
- ↑ Poruk KE, Firpo MA, Adler DG, Mulvihill SJ (2013). "Screening for pancreatic cancer: why, how, and who?". Ann Surg. 257 (1): 17–26. doi:10.1097/SLA.0b013e31825ffbfb. PMC 4113008. PMID 22895395.
- ↑ Greer JB, Brand RE (2007). "Screening for pancreatic cancer: current evidence and future directions". Gastroenterol Hepatol (N Y). 3 (12): 929–38. PMC 3104195. PMID 21960811.
- ↑ Goral V (2015). "Pancreatic Cancer: Pathogenesis and Diagnosis". Asian Pac J Cancer Prev. 16 (14): 5619–24. PMID 26320426.